Human papillomaviruses (HPVs) are responsible for several types of cancer. K14-HPV16 transgenic mice express the HPV 16 early genes, developing multi-step carcinogenesis associated with marked inflammation, as observed in human patients. MicroRNAs (MiRNA) constitute a class of non-coding RNAs that regulate gene expression. In particular, miR-21 has been associated with carcinogenesis. However, little is known about this microRNA in the normal tissue microenvironment and its possible relationship with cancer predisposition.
INTRODUCTION
Human papillomavirus (HPV) infection is considered epidemic and may lead to the development of cancer. In fact, high-risk human papillomavirus, mainly HPV16 and HPV18, are the agents responsible for most cases of cervical cancer and a significant proportion of other types of cancer, such as anogenital and head and neck cancers (Major, Szarka, Sziklai, Gergely, & Czegledy, 2005; Walboomers et al., 1999; Watson et al., 2008) .The prevalence of cervical cancer and high mortality rates, especially in developing countries, is alarming and need immediate attention (Ferlay J, 2013) .
K14-HPV16 transgenic mice are a particularly useful model for to study the development of HPVassociated squamous cell cancers. This model recapitulates multi-step carcinogenesis of uterine cervix and skin, starting with hyperplasia that progresses to dysplasia, in situ carcinoma (CIS) and, eventually, invasive carcinoma (Coussens, Hanahan, & Arbeit, 1996) . In this mouse model, the expression of HPV16 early region genes (E2-E8) is driven by the cytokeratin 14 (K14) promoter, specifically targeting epithelial basal cells (Coussens et al., 1996) . Basal cells are mitotically active and thus may develop further mutations in response to a proliferative stimulus, and the expression of K14 has been shown to persist in well-differentiated squamous carcinomas (Stoler, Kopan, Duvic, & Fuchs, 1988) . Although several K14-HPV16 transgenic animals develop skin hyperplastic and/or dysplastic lesions in several inbred backgrounds, including C57BL/6, BALB/c, and SSIN/SENCAR, only mice backcrossed into the FVB/n background progress to malignant squamous cell carcinomas of two pathological grades, welldifferentiated and moderate/poorly-differentiated, each displaying characteristic features of malignant behavior (Coussens et al., 1996) . Squamous cell carcinomas are observed on 21% of animals aged 8 to 12 months, on the epidermis of the ear, the chest, and the truncal skin (Arbeit, Munger, Howley, & Hanahan, 1994; Coussens et al., 1996; Herber, Liem, Pitot, & Lambert, 1996; Song, Pitot, & Lambert, 1999) . The morphological and molecular similarities between this mouse model and human HPV-induced malignancies (Coussens et al., 1996) , makes it a useful tool to study epigenetic and genetic factors that coordinate malignant conversion and regulate neoplastic progression.
MicroRNAs (miRNAs) are a class of endogenous small, non-coding RNA molecules of about 21 to 23 nucleotides that have the capacity to specifically inhibit translation or induce mRNA degradation, predominantly through targeting the 3′ untranslated regions (UTRs) of mRNA (Garzon, Calin, & Croce, 2009 ). In normal cells, miRNAs control several processes including proliferation, differentiation and apoptosis. Because of their wide variety of targets, miRNAs have been found to affect numerous developmental processes within cells including hematopoietic lineage differentiation, immunity, inflammation, and tumorigenesis (Chen, 2005; Stahlhut Espinosa & Slack, 2006) .
MicroRNA-21 (miR-21) has been implicated in various aspects of carcinogenesis. In some cancers, miR-21 is overexpressed and thus promotes cell proliferation and reduces apoptosis (Chan, Krichevsky, & Kosik, 2005; Iyevleva et al., 2012; Kulda et al., 2010) . Previous studies suggest that, as an oncogenic miRNA, miR-21 has a role not only in tumor growth but also in invasion and metastasis, by targeting multiple tumor/metastasis suppressor genes (Zhu et al., 2008) . Recently, scientific community has started to debate whether miRNAs can be used as possible markers for the occurrence and development of the HPV-associated cancers . However, in this cancers, the interplay between miR-21 and HPV genes remain elusive and poorly understood. The tissue microenvironment is also responsible for miRNAs regulation, and may, in this way, play a role in neoplastic transformation (Whiteside, 2008) .
In the present study, we aimed to analyzed miR-21 expression in skin samples with or without the presence of integrated HPV DNA and with different HPV-associated lesions. For this purpose, we have used K14-HPV16 transgenic mice, (Arbeit et al., 1994) , to analyze miR-21 expression in ear and chest skin samples, evaluating its association with tissue microenvironment and predisposition to HPV-induced carcinogenesis.
MATERIAL AND METHODS

K14-HPV16 transgenic mice
K14-HPV16 mice generation has been previously reported (Arbeit et al., 1994) . K14-HPV16 mice on a FVB/n background were generously donated by Drs. Jeffrey Arbeit and Douglas Hanahan, from the University of California, through the USA National Cancer Institute Mouse Repository. After one week quarantine, the animals were maintained and bred in accordance with Portuguese (Portaria 1005/92 dated October the 23 rd ) and European (EU Directive 2010/63/EU) legislation, under controlled conditions of temperature (23±2 ºC), light-dark cycle (12 h light/12 h dark) and relative humidity (50±10%), using hardwood bedding. A standard diet (4RF21 GLP, Mucedola, Italy) and water were provided ad libitum, and health checks were performed daily. A total of 15 female mice from consecutive litters were selected for the study.
Genotyping of HPV16-E6 and E2
The mice were genotyped at weaning, using tail tip samples. To tissue lysis added 300μL of MagnaPure DNA Tissue Lysis Buffer (Roche®, Indianapolis, USA) and 20 μL of Proteinase K. After, incubated overnight (16h) at 65 °C. Nucleic acids were extracted using the High Pure Viral Nucleic Acid kit (Roche®, Indianapolis, USA) following the manufacturer's instructions. DNA purity was assessed by the ratio of the absorbance values at 260/280 nm, using the NanoDrop® spectrophotometer v3.7 (Thermo Scientific, Wilmington DE, USA). The presence of amplifiable genomic DNA was tested by polymerase chain reaction (PCR) amplification of mouse β-globin using specific primers (Table 1) (Konkel, Tilghman, & Leder, 1978) . The PCR reaction was performed in a 50 μl solution with 1x Taq buffer, 2.0 mM MgCL2, 0.2 mM DNTP'S, 0.50 μM of each primer, 1 U de Taq DNA Polimerase and 0.2 µg of genomic DNA. The amplification conditions were as following: denaturation of DNA template at 94 ºC for 3 min, followed by 35 cycles at 94 ºC for 30 s 60 ºC for 45 s, 72 ºC for 90 s, and a final extension step at 72 ºC for 10 min. The amplified fragment of 494 base pairs (bp) was analyzed by electrophoresis in 1.5 % (w/v) agarose gels stained with ethidium bromide and visualized under UV light.
The integration of HPV was assessed by amplification of HPV16-E6 and HPV16-E2 genes with specific primers (Table 1) , which amplify a region of 130 bp and 184 bp, respectively, (adapted from a protocol described by Cañadas et al. and Ribeiro et al (Canadas et al., 2010; ). The PCR amplification reaction with HPV16-E6 and HPV16-E2 primers was carried in a 50 µl reaction mixture with 1x PCR Buffer, 2.5 mM MgCl2, 0.2 mM DNTP'S, 0.30 µM of each primer, 1 U of Taq DNA polymerase and 0.2 µg of genomic DNA. Thermal cycling was performed as follows: initial denaturation of DNA template at 94 ºC for 2 min, followed by 35 cycles at 94 ºC for 1 min, 60 ºC for 1 min, and 72 ºC for 1 min and a final extension step at 72 ºC for 5 min. The amplified fragment was analyzed by electrophoresis in 1.5 % (w/v) agarose gels stained with ethidium bromide and visualized under UV light.
The resulting genotypes were compared with the respective phenotypes. 
Sample collection
Eight hemizygous (+/-) and seven wild-type (-/-) females were sacrificed at 24 to 28 weeks of age by using sodium pentobarbital followed by intracardiac punction and exsanguination, as indicated by the Federation for Laboratory Animal Science Associations (FELASA). Ear and chest skin samples from each animal (13 samples from transgenic and 14 samples from wild-type animals) were collected into TriPure reagent (Roche® Applied Science), macerated, and kept at -80 ºC until processing. Matched samples were collected into 10% neutral buffered formalin for routine histological processing.
Histological sections (2 µm-thick) were stained with haematoxylin and eosin (H&E) for examination on light microscopy. Samples were classified as normal skin, epidermal hyperplasia and epidermal CIS by two independent researchers (CL and RGC), as previously described (Arbeit et al., 1994) . In order to analyse tumour-associated inflammatory cell infiltration, leukocytes were counted in the neighbouring dermis. Total leukocytes and each leukocytic population were assessed in 3 adjacent high power fields and expressed as the mean ± standard deviation.
Analysis of miRNA expression
Extraction of total RNA from samples preserved in TriPure reagent was performed using the High Pure Viral Nucleic Acid kit (Roche®, Indianapolis, USA), according to manufacturer's instructions.
RNA quality was assessed using NanoDrop® spectrophotometer v3.7 (Thermo Scientific, Wilmington DE, USA).
Hsa-miR-21_000397 and snoRNA-202_001232 were analyzed using two-step real-time PCR protocols cDNA from RT snoRNA-202 was used as endogenous control. Thermal cycling conditions were: 10 min at 95 °C followed by 45 cycles of 15 s at 95 °C and 1 min at 60 °C. All reactions included two-template controls using double distilled water to replace template cDNA.
Statistical Analysis
Data analysis was performed using the software IBM®SPSS ®Statistics for Windows (Version 20.0).
The T-Student test was used in order to evaluate any statistical differences in the normalized expression of the miR-21. In order to analyze the normalized relative expression (-ΔCt) of the different groups, we considered the results corresponding to a 99% representation of the population ( X ± 2SD).
RESULTS
Analysis of genotyping vs phenotyping and tumour-associated inflammatory cell infiltration
In 8 out of 15 mice we observed the presence of HPV16 integration ( Figure 1 ). All animals with integrated HPV16 DNA presented a phenotype characteristic of HPV-associated lesions, as persistent epidermal squamous hyperplasia in various degrees and hyperkeratosis, as previously described (Arbeit et al., 1994) (Figure 2 ). Wild-type mice did not develop any skin lesions. Also, we observed in histologic evaluation that in all cases with integrated HPV16 DNA, the chest skin presented epidermal hyperplasia while the ear skin showed CIS. Wild-type mice presented, as expected, normal skin histology (Figure 3 ).
HPV-transgenic mice showed increased numbers of tumour-associated leukocytes compared with
wild-type animals ( Table 2) The underlying stroma exhibits intense mixed inflammatory cell infiltration and neovascularization. Table 2 . Tumour-associated inflammatory cell infiltration in HPV16 -/-and HPV16 +/-mice.
Total leukocytes and each leukocytic population were assessed in 3 adjacent high power fields and expressed as the mean ± standard deviation.
MiRNA-21 expression profile in skin tissues from wild-type mice
We quantified the miR-21 expression in normal skin tissues (wild-type mice) and we verified that the ear tissues presented lower expression levels compared with chest tissues (p=0.036) (Figure 4a ).
MiRNA-21 expression profile in skin tissues of transgenic mice
To evaluate the miR-21 expression in tissues from transgenic mice, we analyzed ear and chest skin samples. Similarly to that detected in wild-type mice, we observed lower expression levels of miR-21 in ear tissues (histologically presenting with CIS) when compared with chest tissue (histologically presenting with epidermal hyperplasia) (p=0.043) (Figure 4b ). 
Genotype
MiRNA-21 expression profile in tissue of transgenic versus wild-type mice
To investigate a possible direct influence of HPV16 on the miR-21 expression profile, we compared the relative expression between tissues (ear and chest) of transgenic mice and wild-type mice. Our data showed no statistical significant difference in miR-21 expression levels between both groups (p=0.615).
Identically, no differences were found when we compared miR-21 expression in ear (p=0.486) and chest (p=0.731) samples, separately, between transgenic and wild type mice ( Figure 5 ). 
DISCUSSION
The elucidation of the importance of miRNAs in tumor biology is a rapidly growing field in oncology research, because it holds promise for disease prognosis and targets for the development of novel cancer therapeutics (Garzon, Marcucci, & Croce, 2010; Nelson & Weiss, 2008) .
MiR-21 is a highly overexpressed miRNA in several cancers. Its overexpression has been observed in head and neck, cervical, ovarian, lung, liver, stomach and pancreatic cancers (Guo et al., 2009; Hui et al., 2010; Jiang et al., 2008; Lee et al., 2007; T. Yao & Lin, 2012; Zhang et al., 2010) . Previous studies indicate that HPV infection is the main factor driving the transition from normal cervical epithelium to cervical preneoplastic lesions, intraepithelial neoplasia and, successively, to invasive cervical cancer (Bosch & de Sanjose, 2007; zur Hausen, 2002) . The influence of others factors, such as the host microenvironment, remains poorly understood. In particular, no conclusive evidence exists concerning the relation between HPV and miR-21 expression in cervical cancer, the most important HPV-associated tumor.
K14-HPV16 transgenic mice are a useful experimental model for studying HPV-induced carcinogenesis.
The FVB/n mouse strain is particularly prone to HPV-driven carcinogenesis, as other mouse strains (e.g.
Balb/c, C57Bl/6, SSIN/SENCAR) bearing an identical transgene, failed to develop invasive carcinomas (Coussens et al., 1996) . This observation highlights the key role of host factors in the development of HPV-associated tumors.
Our results indicate that, among wild-type mice (HPV-/-), the expression of miR-21 is lower in ear skin tissue compared with chest skin (p=0.036). Furthermore, in matched 24-26 weeks-old transgenic animals (HPV16+/-), we found that CIS had developed in all ear skin samples, whereas chest skin samples only showed epidermal hyperplasia. Consistently, in these samples, miR-21 expression was lower in CIS (ear skin) samples when compared to hyperplasia (chest skin) (p=0,043). We conclude that the expression of miR-21 in normal tissues could be an important factor in the local microenvironment favoring the development of HPV-associated tumors.
Several studies have expanded the concept that inflammation is a critical component of tumor progression, including HPV-associated tumors (Boccardo, Lepique, & Villa, 2010) . Many cancers arise from sites of infection, chronic irritation and inflammation (Coussens & Werb, 2002) . Among other phenomena, inflammation promotes stromal remodeling and inflammatory cell infiltration (Neuchrist et al., 1990; Ortegel, Staren, Faber, Warren, & Braun, 2000) , including monocytes/macrophages, B and T lymphocytes, NK cells, and neutrophils. Our results confirm that tumour progression is accompanied by increased inflammatory cell infiltration, especially macrophages and neutrophils. In our study we found that there is an increased of inflammation with tumor progression by infiltration of leucocytes especially macrophages and neutrophils. In K14-HPV16 transgenic mice, a deficiency in CD4+ T cells has been previously shown to modulate inflammation, delaying neoplastic progression and lowering tumor incidence (Daniel et al., 2003) .
Considerable evidence indicates that miR-21 has anti-inflammatory properties. Previous studies reported that miR-21 silences the pro-inflammatory interleukin 12 (I L-12) (Lu et al., 2011) . IL-12 is a major cytokine that regulates Th1 versus Th2 decisions, primarily by inducing T cells to produce the Th1 cytokine IFN-γ (Gately et al., 1998) , leading to enhanced inflammation and tumor progression. Other studies demonstrated that elevated levels of several pro-inflammatory, type-1 interleukins, like Il-12, were indicators of cervical HPV persistence, underscoring the potential negative biological effects of prolonged inflammation (Scott et al., 2013) . Our results are in accordance with these reports, suggesting that high levels of miR-21 may decrease inflammation, possibly by interacting with Il-12 and, thus, reduce countering malignant transformation.
Furthermore, IL-1β is a target of miR-21 and this cytokine has an important role in inflammation (Apte & Voronov, 2008) . This is a pro-inflammatory cytokine associated with stimulation of the tumor microenvironment in favor of increased cell proliferation and tissue angiogenesis (Voronov et al., 2003) .
These results are consistent with our findings, suggesting that low levels of miR-21 may be associated with high levels of Il-1β, thus promoting the increase of inflammation and, consequently, the carcinogenic process.
Programmed cell death 4 (PDCD4), a tumor suppressor gene, is an important functional target of the miR-21 in several cancers, including in cervical cancers (Q. Yao, Xu, Zhang, Zhou, & Qu, 2009 ). This target is a pro-inflammatory protein that promotes activation of the transcription factor NF-kB and suppresses the anti-inflammatory interleukin 10 (IL-10). Some studies observed that miR-21 directly blocked NF-kB activity and promoted IL-10 production (Sheedy et al., 2010) . NF-kB can act as an oncogene through its ability to stimulate inflammation, cell proliferation and survival. NF-kB is constitutively activated in several human cancers (Li, Withoff, & Verma, 2005) , including cervical cancer (Branca et al., 2006; Nair, Venkatraman, Maliekal, Nair, & Karunagaran, 2003) and has been proposed to be an important link between chronic inflammation and cancer (Karin, 2009 ). In our study, low levels of miR-21 may promote NF-kB activation, through of PDCD4 expression, and, thus, increase the predisposition to cancer development.
Conclusion
Previous data correlating miR-21 downregulation with increased inflammation, may explain our findings suggesting that tissues with lower miR-21 expression are more prone to cancer progression. These findings are important in the quest to gauge the utility of miR-21 expression in evaluation of tissues with higher predisposition to cancer development.
